Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – In patients with hypertension, physicians should assess the presence of subclinical organ damage, an indication of high absolute risk for cardiovascular disease (CVD).…
NEW YORK (Reuters Health) – Men with localized prostate cancer treated with external beam radiotherapy (EBRT) are apt to have better sexual function afterward than men treated with…
NEW YORK (Reuters Health) – Long-term treatment with low-dose trimethoprim-sulfamethoxazole is modestly effective in preventing urinary tract infections (UTI) in predisposed children, according to a report in The…
NEW YORK (Reuters Health) – Phenothiazines are more effective than other agents, including opioids, for the treatment of acute migraine, according to a meta-analysis published in the October…
NEW YORK (Reuters Health) – Women who regularly use nonsteroidal anti-inflammatory drugs (NSAIDs) have better survival after a colorectal cancer (CRC) diagnosis, research indicates. “A wide body of…
NEW YORK (Reuters Health) – Liquid-based cytology is no better than conventional Pap tests in detecting cervical cancer precursors, according to a report in the Journal of the…
NEW YORK (Reuters Health) – Although diclofenac is commonly used to treat acute pain in children, it is not licensed for this purpose in all age groups. A…
NEW YORK (Reuters Health) – For hypothyroid patients taking levothyroxine, therapeutic levels are best maintained by taking the medication in a fasting state, at least an hour before…
NEW YORK (Reuters Health) – A central pulse pressure (PP) of 50 mmHg or higher is predictive of future MI, coronary heart disease, and other cardiovascular events, according…
NEW YORK (Reuters Health) – In patients with newly diagnosed multiple myeloma, combining the thalidomide analog lenalidomide with low-dose dexamethasone led to better short-term survival than lenalidomide plus…
